BridgeMD
New treatment option for Herpes Zoster (HZ)
Official title Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
ClinicalTrials.gov ID: NCT06978192
What this study is testing
What is dexmedetomidine nasal spray group?
dexmedetomidine nasal spray group is an investigational medicine, being studied as a potential treatment for herpes zoster (hz).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Participants will be invited to take part in clinical research. This informed consent form will provide information to the participants to help them decide whether to participate in the clinical study.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Patients with adverse reactions that are not effective in conventional drug treatment and cannot tolerate drugs
- The pain is located in the corresponding innervated are
- The pain affects the patient's daily life or work
- Diagnostic nerve block is effective and pain limited
- Recurrent herpes zoster pain
You likely can't join if
- Infection at the puncture site, systemic infection that may spread, and malignant tumors near the puncture
- There are contraindications in minimally invasive treatment therapy such as coagulation function and platelet dysfunction
- Allergies to local anesthetics and inhalants
- Heart, lung, liver, kidney and other important organ failure, can not tolerate surgery
- Severe endocrine system diseases or long-term use of hormone or immunosuppressive therapy
- Patients with cardiac pacemakers, pregnant or lactating women
See the full eligibility criteria
- Patients with adverse reactions that are not effective in conventional drug treatment and cannot tolerate drugs
- The pain is located in the corresponding innervated are
- The pain affects the patient's daily life or work
- Diagnostic nerve block is effective and pain limited
- Recurrent herpes zoster pain
- Patients with shingle-related pain aged 40-85 years
- Infection at the puncture site, systemic infection that may spread, and malignant tumors near the puncture
- There are contraindications in minimally invasive treatment therapy such as coagulation function and platelet dysfunction
- Allergies to local anesthetics and inhalants
- Heart, lung, liver, kidney and other important organ failure, can not tolerate surgery
- Severe endocrine system diseases or long-term use of hormone or immunosuppressive therapy
- Patients with cardiac pacemakers, pregnant or lactating women
- Patients with cognitive dysfunction or poor coordination
- Patients who have been treated with electrical stimulation or PRF
The study team makes the final eligibility decision.
Where it's taking place
- Zunyi, Guizhou, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zunyi, Guizhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.